The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC.

导出 LinkOut

翻译打印收藏纠错

第一作者： Qi,Peng

第一单位： Ministry of Education Key Laboratory of Diagnostic Medicine, and School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.

作者： Qi,Peng ^[1] ; Yan,Liu ^[1] ; Xuehua,Kong ^[1] ; Jie,Xian ^[2] ; Lin,Ye ^[2] ; Li,Yang ^[3] ; Shuliang,Guo ^[3] ; Yan,Zhang ^[1] ; Lan,Zhou ^[1] ; Tingxiu,Xiang ^[2]

作者单位： Ministry of Education Key Laboratory of Diagnostic Medicine, and School of Laboratory Medicine, Chongqing Medical University, Chongqing, China. ^[1] Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. ^[2] Department of Respiratory & Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. ^[3]

关键词 CpG methylation FOXM1 SCARA5 non-small cell lung cancer tumor marker

DOI 10.3389/fonc.2021.666589

PMID 34150631

发布时间 2022-04-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交